Curated News
By: NewsRamp Editorial Staff
December 26, 2024
Securities Class Action Lawsuit Filed Against Applied Therapeutics, Inc.
Discuss on Reddit
LinkedIn
Telegram
GithubTLDR
- Lead plaintiff deadline for securities class action lawsuit against Applied Therapeutics, Inc. is February 18, 2025.
- Investors who purchased Applied Therapeutics securities between January 3, 2024, and December 2, 2024, can seek lead plaintiff representation.
- Kessler Topaz Meltzer & Check, LLP aims to protect investors from fraud by prosecuting securities class actions.
- Applied Therapeutics faces lawsuit for alleged misconduct in trial protocol adherence for drug candidate govorestat.
Impact - Why it Matters
This news matters as it highlights allegations of misconduct by Applied Therapeutics, potentially impacting investors who purchased securities during the specified period. Investors have the opportunity to seek appointment as a lead plaintiff representative, emphasizing the importance of understanding their rights and potential recovery options.
Summary
The law firm of Kessler Topaz Meltzer & Check, LLP has filed a securities class action lawsuit against Applied Therapeutics, Inc. on behalf of investors who purchased securities during a specific period. The lawsuit alleges that Applied Therapeutics did not adhere to trial protocol and good clinical practices for its drug candidate, govorestat, posing a risk of FDA rejection.
Investors have until February 18, 2025, to seek appointment as a lead plaintiff representative through Kessler Topaz Meltzer & Check, LLP. The firm encourages investors who suffered losses to contact them for more information about the case.
Source Statement
This curated news summary relied on this press release disributed by NewMediaWire. Read the source press release here, Securities Class Action Lawsuit Filed Against Applied Therapeutics, Inc.
